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encoded by eat-4 as well as three gluta-
mate receptors all reduced excess fat in
daf-7 mutants while retaining wild-type
feeding rates. Since fasting leads to
changes in expression of key metabolic
genes (Van Gilst et al., 2005), future stud-
ies promise to reveal the role of glutamate
signaling in the regulation of these genes
and in other processes leading to in-
creased fat synthesis.
This is not the first report demonstrating
opposite effects of a signal affecting fat
storage and feeding behavior. Several
months ago this same group documented
the opposing consequences of exoge-
nous serotonin on feeding (it increases
feeding rate) and fat storage (it reduces
fat stores) (Srinivasan et al., 2008). Taken
together, the two Ashrafi lab studies
clearly show that a 25% change in pha-
ryngeal pumping rate is not sufficient
to affect fat storage. Importantly, these
studies identifiedpreviouslyunknowncon-
nections between serotonin and TGF-b
signals and fat metabolism pathways,
and showed that themechanisms regulat-
ing metabolism are distinct from those
controlling pharyngeal pumping rates.
Why does a reduced TGF-b signal lead
to increased fat stores but decreased
rate of feeding? DAF-7 plays a key role
during larval stages, where development
of a dauer larva involves the accumula-
tion of fat stores, even though dauer lar-
vae display no pharyngeal pumping (Sav-
age-Dunn, 2005). At the adult stages
examined in this study, C. elegans is
clearly able to ingest enough food in
spite of their reduced pharyngeal pump-
ing to supply the calories for adequate
fat storage. This leads to the question
of whether the rate of pharyngeal pump-
ing is the most relevant way to quantify
feeding. A recent study demonstrated
that when feeding on particular bacterial
strains, C. elegans become quiescent,
essentially ceasing movement and pha-
ryngeal pumping (You et al., 2008). The
daf-7 TGF-b mutant, however, showed
more frequent periods of movement
and feeding than wild-type (reduced qui-
escence) (You et al., 2008), consistent
with higher fat stores. It is possible that
the time spent in quiescent versus active
states may correlate more closely with
fat storage levels than does the pumping
rate during active periods.
The ability to alter metabolism when
food is scarce is an adaptation that pro-
motes animal survival but wreaks havoc
on human dieters who, after losing
weight on a reduced-calorie diet, gain
it back readily after resuming their previ-
ous eating habits. Future studies using
the powerful tools available in C. ele-
gans promise to unravel the highly com-
plex processes involved in maintaining
energy balance in uncertain and chang-
ing environments and may provide in-
sight into molecular targets for antiobe-
sity drugs.
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Exercise leads to changes in muscle phenotype with important implications for exercise performance and
health. A recent paper inCell by Narkar et al. (2008) shows that many of the adaptations in muscle phenotype
elicited by exercise can be mimicked by genetic manipulation and drug treatment in mice.Exercise training leads tomultiple adapta-
tions in the body. Well-documented ef-
fects are within the cardiovascular and
the musculoskeletal systems, but in real-
ity there are probably few, if any, organs
that are not affected. These adaptations
result in increased physical performance
and have multiple health benefits. In
fact, physical inactivity is now recognized96 Cell Metabolism 8, August 6, 2008 ª2008as a major health hazard that is at least
partly responsible for many life-style dis-
orders such as obesity, cardiovascular
disease, and type 2 diabetes (Lees and
Booth, 2005). Narkar et al. (2008) show
that several of the adaptations in muscle
phenotype thought to be important for
health in humans can be mimicked by
drug treatment in mice.Elsevier Inc.Based upon expression of myosin
heavy chains, muscle fibers are com-
monly classified as type I slow-twitch
fibers, with a high mitochondrial content,
or type II fast-twitch fibers, which have
fewer mitochondria and exhibit a more
glycolytic phenotype. In humans, the
type II fibers are subdivided into the
more oxidative type IIa and the less
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Previewsoxidative, but more glycolytic, type IIx
fibers. In rodents, an even faster type IIb
fiber can also be found. As a consequence
of physical training, a number of changes
occur in skeletal muscle, for example
increased mitochondrial biogenesis, in-
creased content of several proteins in
the oxidative pathway and also that of
the glucose transporter GLUT4, and in-
creased capillarization and fiber type
remodeling from less to more oxidative
fibers. These adaptations contribute to a
higher maximal rate of oxygen consump-
tion during exercise in addition to in-
creased exercise performance, and they
also result in increased insulin sensitivity.
Conversely, insulin resistance and type 2
diabetes are accompanied by a reduction
in expression of genes involved in oxida-
tive phosphorylation (Mootha et al.,
2003). Similarly, physical inactivity is as-
sociated with fiber-type transformation
toward a less oxidative phenotype and
diminished insulin sensitivity.
The molecular signaling mechanisms
underlying adaptations to increased
physical activity have been intensely
investigated for the last 10 of years.
AMP-activated protein kinase (AMPK) is
a cellular fuel gauge, which is activated
when cellular energy status is threatened.
It acts to restore energy balance both by
enhancing processes that generate ATP
and inhibiting others that consume ATP.
It has been recognized that AMPK also
has much wider actions, e.g., in gene
expression. AMPK is activated during
exercise (Wojtaszewski et al., 2000), and
studies from the Winder laboratory
showed that chronic activation of AMPK
with the AMP mimetic agent, AICAR, led
to increased activity of the mitochondrial
enzyme citrate synthase (CS) and in-
creased GLUT4 expression, suggesting
that AMPK may be an important signaling
molecule for exercise adaptations in skel-
etal muscle (Winder et al., 2000). Other
studies have shown that overexpression
of PGC1a in mouse skeletal muscle in-
duced dramatic changes in muscle phe-
notype, including enhancedmitochondrial
biogenesis and muscle fiber remodeling
(Lin et al., 2005). Coupled with the obser-
vation that PGC1a can be activated by
AMPK (Jager et al., 2007), an emerging
scenario has been that AMPK activation
during exercise leads to PGC1a activation
and muscle phenotype changes. How-
ever, PGC1a may also be activated byFigure 1. Complex Regulation of Muscle Phenotype
The regulation of muscle phenotype is extremely complex, involving many signaling molecules such as
AMPK, CaMK, calcineurin, p38, and transcription factors (NFAT, PPARb/d, PGC-1a, and MEF-2). The
paper by Narkar et al., 2008 suggests that combining stimulation of AMPK and PPARd leads to an
oxidative red phenotype in skeletal muscle. Although this is probably a desirable phenotype, perhaps
stimulation can become too intense for some fibers? Illustration by Freja P. Pilegaard.the Ca-signaling pathway involving both
the Ca-sensitive phosphatase calcineurin
and CaMK and by p38 MAPK (Schiaffino
et al., 2007). Finally, mice that express
an activated form of PPARd display a co-
ordinated increase in oxidative enzymes,
mitochondrial biogenesis, an increased
proportion of slow-twitch fibers, and
increased running performance (Wang
et al., 2004). Thus, a whole plethora of
signaling cascades and transcription fac-
tors seem to be involved in the control of
muscle phenotype.
Although there seems to be a connec-
tion betweenmuscle phenotype and insu-
lin action in humans, the link has not yet
been firmly established experimentally.
However, there is more definite support,
based on rodent studies, for the concept
that enhanced gene expression leading
to an oxidative phenotype of skeletalmus-
cle can protect against the development
of insulin resistance. Mice overexpressing
constitutively active PPARd or treated
with the PPARb/d agonist GW1516 were
protected against development of obesity
and insulin resistance when fed a fat-rich
diet (Wang et al., 2004). Mice overex-
pressing active calcineurin were also
protected against insulin resistance onCell Metabolisa high-fat diet, and AICAR treatment as
well as exercise training of obese ZDF
rats prevented development of diabetes
(for references see (Schiaffinoet al., 2007).
In a recent issue of Cell, Narkar et al.
showed that treatment of mice with
AICAR resulted in marked muscle reprog-
ramming toward a more oxidative pheno-
type and increased running performance
in a PPARb/d-dependent manner, thus
suggesting molecular crosstalk between
AMPK and PPARb/d. The same laboratory
had previously shown similar muscle
phenotype from overexpression of a con-
stitutively active PPARd (Wang et al.,
2004). Interestingly, in the present study
they demonstrate that while treating wild-
type (WT) mice with the PPARb/d agonist
GW1516 does induce some oxidative
reprogramming, but no fiber type switch
or increased running performance is ob-
served. Presumably, the effect of the drug
in vivo is not as potent a stimulus as over-
expressing the active PPARd, or perhaps
stimulation needs to be early in life to be
maximally effective. However, in exercise-
trained WT mice also treated with the GW
1516 compound, genetic reprogramming
and running performance were increased
more so than in mice that were justm 8, August 6, 2008 ª2008 Elsevier Inc. 97
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Previewsexercise trained, suggesting that an exer-
cise signal (AMPK?) enhances the ability
of PPARb/d agonists to induce muscle re-
programming. Furthermore, the authors
demonstrated that treating WT mice with
AICAR increased the running ability of
these mice without training. While the abil-
ity of AMPK to increaseexpressionofmito-
chondrial proteins and the glucose trans-
porter has been known for years (Winder
et al., 2000), its effect on running perfor-
mance had not been previously reported.
Narkar et al. also propose that targeting
the AMPK-PPARb/d signaling pathway
may be a novel pharmacological strategy
to reprogram muscle to an endurance
phenotype, which may be of health bene-
fit for people who may not be able to or
choose not to exercise regularly (Figure 1).
Paradoxically, ablation of the alfa2 AMPK
subunit (Jorgensen et al., 2007) or of
PGC-1a (Leick et al., 2008) in mice causes
reduced basal levels of mitochondrial en-
zymes but, surprisingly, when these mice
are exercise trained they are able to in-
crease mitochondrial enzymes just as
well as WT mice. Such data highlight the
extreme complexity and redundancy in
the signaling mechanisms that control
muscle-fiber phenotype.
The question remains as to what extent
the data from Narkar et al. can be extrap-98 Cell Metabolism 8, August 6, 2008 ª2008olated to humans. While exercise training
can certainly induce increased oxidative
potential and muscle-fiber reprogram-
ming from type IIx to IIa, conversion
from type IIa to type I is open to debate.
Furthermore, in humans running perfor-
mance seems linked more to cardiovas-
cular performance, as indicated by the
maximal oxygen consumption, than to
muscle-fiber type distribution (Foster
et al., 1978). Given the complexity of exer-
cise as a stimulus that affects multiple
(all?) organs, it would seem somewhat
premature to conclude that AMPK and
PPARd agonists are exercise mimetics
until other organs, besides skeletal mus-
cle, are investigated. Nevertheless, the
results from Narkar et al. highlight impor-
tant new molecular mechanisms that are
not only important for our understanding
of muscle biology, but ultimately for
opening new avenues for pharmacologic
targets important for health.
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